BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 25, 2011
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cytokinetics completes private placement of common stock and preferred stock

Cytokinetics Inc. (NASDAQ:CYTK), South San Francisco, Calif.
Business: Cardiovascular, Musculoskeletal, Cancer
Date completed: 4/18/11
Type: Private placement of common stock and preferred stock...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >